Kit Check Announces Strategic Additions to Leadership Team

March 26, 2019 Off By BusinessWire

Leading automated medication management company brings on industry
experts to increase impact amongst hospitals across the United States

WASHINGTON–(BUSINESS WIRE)–Kit
Check, the leader in automated medication management solutions for
hospitals, today announced new appointments to its leadership team to
help foster the company’s continuous growth and increase its recognition
amongst hospitals across the country. The appointments cement the
company’s focus on improving medication management processes within the
hospital as well as amplify their continued efforts to decrease drug
diversion.

As the opioid epidemic continues to ravish communities across the
country, Kit Check is focused on helping hospitals and healthcare
networks achieve 100% diversion audits by utilizing its Bluesight
for Controlled Substances (BCS) software. BCS uses machine learning
and artificial intelligence (AI) to identify anomalous behavior and curb
the theft of controlled substances, such as opioids, within the
hospital. Currently adopted in over 60 hospitals, BCS saves hospitals
time and money, while also creating a safer environment for patients.

“Since Kit Check was founded, we have focused on identifying various
ways hospital pharmacies can leverage technology to improve their
operations. Rather quickly, we realized the unmet need of diversion
auditing, so we developed Bluesight,” said Kevin MacDonald, chief
executive officer and co-founder of Kit Check. “Today, we are at a
turning point in the industry where a social epidemic is finding its way
into our hospital systems. Our mission now is to further educate and
help hospitals combat this issue with our technology. By bringing on
smart, strategic executives to the table, we can better underscore the
importance of medication management and diversion detection to improve
efficiencies and keep patients and our communities safe.”

The industry experience and fresh perspectives of the appointees shine a
light on Kit Check’s dedication to growing its customer base and
bringing the latest technologies to hospital pharmacies. Joining Kit
Check and its efforts to increase safety across hospitals include: Amy
Langan, Chief Marketing Officer; Doug Zurawski, Pharm.D., Senior Vice
President of Clinical Strategy; MaryAnn Jensen, Vice President of
Strategic Marketing; Eric Bolling, Executive Vice President.

Amy Langan, chief marketing officer, brings over 25 years of product,
marketing and development experience in the pharmaceutical, health and
health care industries to the team. Before joining Kit Check in
January 2019, Langan served as vice president of marketing and
business development at AmerisourceBergen where she focused on
providing pharmaceutical products, value-driving services and business
solutions that improve access to care. Most recently, Langan served as
senior vice president of marketing and sales at Fresenius Kabi where
she worked closely with generic injectable drugs for infusion,
transfusion and clinical nutrition.
Eric Bolling, executive vice president, brings over 30 years of
experience to the company’s sales division. Prior to joining Kit Check
in January 2019, Eric was General Manager of Enterprise Corporate
Accounts at Cardinal Health. Professionally, he has a passion for
sales leadership, enterprise sales, and strategic client development.
Doug Zurawski, Pharm.D., was named senior vice president of clinical
strategy in January 2019. Zurawski brings a wealth of knowledge to Kit
Check as his professional passions include the advancement of clinical
pharmacist practice and patient safety through health system pharmacy
leadership, and hospital pharmacy automation technology sales and
consulting. Zurawski has clinical practice experience including
leadership positions at Ascension Health, the Detroit Medical Center
and the University of Iowa Hospitals and Clinics.
MaryAnn Jensen, vice president of strategic marketing, has been
extensively involved in the healthcare industry for over 20 years in
business development, process development, implementation, and sales.
Jensen brings experience from Capital Returns, Inc., where she was
responsible for developing procedures for highly regulated areas such
as controlled substance processing and tracking.

To find out how Bluesight for Controlled Substances works with hospital
pharmacies to fight diversion, meet with Kit Check’s leadership team at TSHP’s
Annual Seminar April 12-14, 2019 in Frisco Texas. If you are unable
to attend but are interested in learning more, you can request a demo here.

About Kit Check™
Kit Check is the leading provider of
automated medication management solutions for hospital pharmacies. Our
solutions blend powerful machine learning and advanced tracking
technology to streamline medication inventory, workflow, and auditing
processes and help hospital pharmacies cut costs, reduce risk, and get
more done. To date, our more than 400 U.S. and Canadian hospital
partners have tracked over 50 million medications using the Kit Check
and Bluesight™ for Controlled Substances software.

More information about Kit Check and our software solutions can be found
at https://kitcheck.com/.